CCL2 and head and neck squamous cell carcinoma: Then we performed the pulldown assay to access Rac1 and found the overexpression of GTP-bound Rac1 in HNSCC cells after treatment with CCL2 but not overexpression of total Rac1 (Fig. 3C).